Investment
Features
FeesSafety
Academy
More
Pluang+

Compare HCA Health Inc (HCA) vs Strategy Inc. (MSTR) Price & Performance

HCA Health IncTrade
Strategy Inc.Trade

Price performance (Past 24H)

Key statistics

HCA Health Inc vs Strategy Inc. — how do they compare? HCA Health Inc trades at $443.69 (market cap $96.35B), while Strategy Inc. trades at $154.16 (market cap $60.40B). The key difference: HCA Health Inc is the larger of the two by market cap, and HCA Health Inc pays a 0.7% dividend while Strategy Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Strategy Inc. for 112 Days on average.

HCAMSTR
Market Cap
$96.35B$60.40B
Volume
1,079,45323,421,830
Sector
HealthTechnology
52-Week High
$545.13$320.29
52-Week Low
$361.32$82.31
Typical Hold Time
76 Days112 Days
Enterprise Value
$146.88B$79.16B
Dividend Yield
0.7%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

HCA Health Inc

HCA Healthcare (HCA) trades at $439.17, up 1.61% on the day, with a bullish technical signal and strong fundamentals. The stock shows consistent revenue growth, reaching $75.6B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst consensus is bullish with a $461.12 price target, supported by solid cash flow from operations of $12.64B and a net income margin of 8.77%.

The outlook remains positive given earnings momentum and operational efficiency, but risks include ongoing legal investigations and high debt levels. Upside potential exists if the company maintains its earnings beat streak and manages payer-mix challenges effectively.

Strategy Inc.

MSTR stock trades at $153.37, down 6.79% today, reflecting volatility despite a bullish technical signal. The company reported a net loss of $3.85B in 2025 with a negative net income margin of -6,102.96%, though revenue grew slightly to $477.23M. Analyst consensus remains optimistic with a $252 price target, but earnings misses in recent quarters highlight operational challenges.

The outlook hinges on improving profitability and Bitcoin market stability, offering upside if earnings rebound. Key risks include persistent losses, high debt, and sensitivity to macroeconomic factors. Investors should weigh analyst optimism against fundamental weaknesses before considering a position.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

HCA
100% Buy0% Sell
Avg holding period · 76 Days
MSTR
54% Buy46% Sell
Avg holding period · 112 Days

Top news

Latest headlines on both assets

About HCA Health Inc

HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.

Read more on HCA →

About Strategy Inc.

MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web

Read more on MSTR →